Literature DB >> 20178376

Molecular basis of activation of endopeptidase activity of botulinum neurotoxin type E.

Roshan V Kukreja1, Shashi K Sharma, Bal Ram Singh.   

Abstract

Botulinum neurotoxins (BoNTs) are a group of large proteins that are responsible for the clinical syndrome of botulism. The seven immunologically distinct serotypes of BoNTs (A-G), each produced by various strains of Clostridium botulinum, act on the neuromuscular junction by blocking the release of the neurotransmitter acetylcholine, thereby resulting in flaccid muscle paralysis. BoNTs are synthesized as single inactive polypeptide chains that are cleaved by endogenous or exogenous proteases to generate the active dichain form of the toxin. Nicking of the single chain BoNT/E to the dichain form is associated with 100-fold increase in toxicity. Here we investigated the activation mechanism of botulinum neurotoxin type E upon nicking and subsequent reduction of disulfide bond. It was observed that nicking of BoNT/E significantly enhances its endopeptidase activity and that at the physiological temperature of 37 degrees C the reduced form of nicked BoNT/E adopts a dynamically flexible conformation resulting from the exposure of hydrophobic segments and facilitating optimal cleavage of its substrate SNAP-25. Such reduction-induced increase in the flexibility of the polypeptide folding provides a rationale for the mechanism of BoNT/E endopeptidase against its intracellular substrate, SNAP-25, and complements current understanding of the mechanistics of interaction between the substrate and BoNT endopeptidase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178376      PMCID: PMC3720690          DOI: 10.1021/bi902096r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  40 in total

1.  High-level expression, purification, and characterization of recombinant type A botulinum neurotoxin light chain.

Authors:  L Li; B R Singh
Journal:  Protein Expr Purif       Date:  1999-12       Impact factor: 1.650

2.  Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B.

Authors:  S Swaminathan; S Eswaramoorthy
Journal:  Nat Struct Biol       Date:  2000-08

Review 3.  Botulinum toxin (Botox) to enhance facial macroesthetics: a literature review.

Authors:  Sarosh F Dastoor; Carl E Misch; Hom-Lay Wang
Journal:  J Oral Implantol       Date:  2007       Impact factor: 1.779

Review 4.  Botulism diagnostics: from clinical symptoms to in vitro assays.

Authors:  Shuowei Cai; Bal Ram Singh; Shashi Sharma
Journal:  Crit Rev Microbiol       Date:  2007 Apr-Jun       Impact factor: 7.624

5.  Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation.

Authors:  Desigan Kumaran; Subramaniam Eswaramoorthy; William Furey; Jorge Navaza; Martin Sax; Subramanyam Swaminathan
Journal:  J Mol Biol       Date:  2008-12-24       Impact factor: 5.469

6.  Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.

Authors:  Sheng Chen; Cherisse Hall; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2008-05-29       Impact factor: 5.157

7.  Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility.

Authors:  Nicholas R Silvaggi; Grant E Boldt; Mark S Hixon; Jack P Kennedy; Saul Tzipori; Kim D Janda; Karen N Allen
Journal:  Chem Biol       Date:  2007-05

Review 8.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

9.  Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain.

Authors:  Axel T Brunger; Mark A Breidenbach; Rongsheng Jin; Audrey Fischer; Jose S Santos; Mauricio Montal
Journal:  PLoS Pathog       Date:  2007-09-07       Impact factor: 6.823

10.  Substrate binding mode and its implication on drug design for botulinum neurotoxin A.

Authors:  Desigan Kumaran; Richa Rawat; S Ashraf Ahmed; Subramanyam Swaminathan
Journal:  PLoS Pathog       Date:  2008-09-26       Impact factor: 6.823

View more
  3 in total

1.  Amyloid histology stain for rapid bacterial endospore imaging.

Authors:  Bing Xia; Srigokul Upadhyayula; Vicente Nuñez; Pavel Landsman; Samuel Lam; Harbani Malik; Sharad Gupta; Mohammad Sarshar; Jingqiu Hu; Bahman Anvari; Guilford Jones; Valentine I Vullev
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

2.  Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.

Authors:  Dongxia Wang; Joan Krilich; Jakub Baudys; John R Barr; Suzanne R Kalb
Journal:  Anal Biochem       Date:  2014-09-16       Impact factor: 3.365

3.  Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.

Authors:  Sebastian Miethe; Christine Rasetti-Escargueil; Arnaud Avril; Yvonne Liu; Siham Chahboun; Hannu Korkeala; Christelle Mazuet; Michel-Robert Popoff; Thibaut Pelat; Philippe Thullier; Dorothea Sesardic; Michael Hust
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.